Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretro
about
Animal Models for HIV Cure ResearchPerspectives for immunotherapy: which applications might achieve an HIV functional cure?Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolutionTherapy for persistent HIV.Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcomeGag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study.Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapyHuman immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapyShort-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapyIncomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia.Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy.Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapyGenotypic and functional properties of early infant HIV-1 envelopesAbsence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoirGag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With RaltegravirMonitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.Well-mixed plasma and tissue viral populations in RT-SHIV-infected macaques implies a lack of viral replication in the tissues during antiretroviral therapy.The role of HIV integration in viral persistence: no more whistling past the proviral graveyard.An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cellsHIV reservoirs and latency models.HIV-1 Reservoirs During Suppressive Therapy.Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it?HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapy.Persistent HIV-1 replication during antiretroviral therapy.The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research.Residual viremia in patients on antiretroviral therapy incorporating nevirapine is not associated with the gag-specific cellular immune response.What do we measure when we measure cell-associated HIV RNA.Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.
P2860
Q26767476-E87B2B76-25D3-43EC-B86F-6BBC471BEFC1Q28078726-A7184629-74B4-4227-96D5-16848AD69BC8Q28539563-0C6824B1-3FF2-4092-919E-B1B7EFEEC72FQ30386370-60B6EAAC-0392-48D6-B579-CA80D2549F5DQ33521702-8146D8B6-269B-4166-8E8E-8C6658582A7BQ33629212-D972B2AB-C909-433A-9DBE-F83F35BA3F6BQ33721466-3825E7E9-CB4C-4FC6-8BD8-A63CCD1FDA77Q33952015-1BDE699C-6971-40E6-8206-37A1DA57931EQ33962223-C458AEAD-D92E-4925-A8EC-FD25334B743BQ34324005-672A555A-BF3C-4C1D-BBFA-F68FF1C11E61Q34485122-72A5EAAF-CBAA-49ED-ADF7-3865EE747EC8Q35126342-72070B71-9509-48B5-AEE9-74DE22FFF3E8Q35289861-E8045914-E9F4-4B04-B5B4-8D9A0DFAE428Q35729054-894C8033-0FD3-45AF-A94A-FE1B01093408Q35857687-797A2EA6-D643-41E8-BA2E-67E3F4C0DE97Q35864285-CD5840F3-955D-4ACE-AD41-4E700C2A70A9Q36051970-14B8E142-7100-4B18-97C0-45F334B194A2Q36102538-44F404A2-64AD-4B5B-A22C-C032D2425996Q36273849-4655E69C-987F-4540-8ED1-45DB4E809EA2Q36515181-45DAD466-6A38-4B44-AFFC-BF076CE1F339Q36559821-B47888EB-E6B0-4ECB-BE59-EB1D34D3FDECQ36746403-EA6B3EF6-031D-4D0F-A579-5161D5B30E4FQ37656766-33E48CB0-DDD0-48CB-8590-D6C365447F06Q38086435-451D95E8-21A8-46AA-9EB4-4EB0493CFD4CQ38380240-81ACACF6-C3A0-47EA-A9D2-E71C8368503AQ38808266-762D3D95-FAA0-4F2B-912B-BDB16E5F1EBFQ42037424-27A83377-652F-422F-8FE3-65930EEC3476Q42263433-D3F04A25-D034-4342-91E2-8859464C0E65Q47548192-E4022AC0-DC3F-4E09-98CF-71AB94046638Q55154648-A2A88700-F0DE-4E53-BA3B-7B76DCD4FED5
P2860
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretro
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Identification of ongoing huma ...... essive highly active antiretro
@ast
Identification of ongoing huma ...... essive highly active antiretro
@en
Identification of ongoing human immunodeficiency virus type 1
@nl
type
label
Identification of ongoing huma ...... essive highly active antiretro
@ast
Identification of ongoing huma ...... essive highly active antiretro
@en
Identification of ongoing human immunodeficiency virus type 1
@nl
prefLabel
Identification of ongoing huma ...... essive highly active antiretro
@ast
Identification of ongoing huma ...... essive highly active antiretro
@en
Identification of ongoing human immunodeficiency virus type 1
@nl
P2093
P2860
P921
P356
P1433
P1476
Identification of ongoing huma ...... active antiretroviral therapy
@en
P2093
Carlum Shiu
Carrie Ziemniak
Coleen K Cunningham
Deborah Persaud
Katherine Luzuriaga
Lawrence Fox
Marvin Belzer
Pediatric AIDS Clinical Trials Group P1059 Team
Petronella Muresan
Thomas Greenough
P2860
P304
P356
10.1128/JVI.00570-09
P407
P577
2009-07-15T00:00:00Z